Menarini has been involved in ensuring health and well-being for over 135 years. An entrepreneurial history that has always put quality first, together with the constant search for innovative and sustainable production systems. Environmental awareness is a paramount topical element when researching development strategies. This is implemented through technological solutions that focus on the recovery […]
Read more28 February is universally recognised as World Rare Disease Day. This is a significant date for the Menarini Group, which counts among its core values the research on yet unresolved pathologies and infectious diseases, with particular attention to rare diseases. The Group is committed to the development of new therapies that can address the unmet […]
Read moreBERLIN-CHEMIE Menarini, the German company part of the Menarini Group, launched an innovative and original initiative in September 2020: The weekly podcast “EinBlick – Der Podcast” (a play on the words ein Blick, a glance, and Einblick, insight), that addresses topics in health policy, pharmaceutical policy and digital health. The podcast is one of today’s […]
Read moreThe development of a socially responsible corporate culture is achieved through the promotion of both cultural and solidarity initiatives. For many years, the Menarini Group has been actively involved in sponsoring poverty alleviation campaigns, supporting sustainable lifestyles and promoting the projects of local and regional communities near the Group’s production and research centres. Several of […]
Read moreTogether, we make a difference Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is a rare hematologic malignancy that often manifests with skin lesions. Although BPDCN is mostly diagnosed in elderly patients, it may occur at any age,1,2 with men three times more likely to be affected than women. There are roughly 700 cases in the United […]
Read moreEstablished in 1976, the “Fondazione Internazionale Menarini” aims to promote research and knowledge in the fields of biology, pharmacology and medicine, as well as economics and human sciences, throughout the world. In the words of Sergio Gorini, the Foundation’s first president, the Institution is conceived as “a meeting point for all friends with common ideals […]
Read more